🔥 Friday 31 January 2025 Fri, 31 Jan 2025

Lode Resources has completed the acquisition of the Montezuma Antimony Project in Tasmania, delivering high-grade drill results that bolster its strategy to become a leading Australian antimony producer amid global supply shortages.

Aspire Mining Limited has made significant strides in developing its Ovoot Coking Coal Project, progressing construction tenders and customer engagement despite a challenging coal market.

Tolu Minerals reports significant progress in recommencing production and expanding resources at its Tolukuma mine, underpinned by strategic hires and advanced geophysical surveys.

Thunderbird Resources has significantly bolstered its portfolio with the acquisition of the Rockvale and Kookabookra antimony-gold projects in New South Wales, alongside promising uranium exploration results in Canada. These developments position the company for a dynamic 2025 exploration season.

Excite Technology Services has achieved positive EBITDA in December 2024, driven by strong revenue growth and record customer receipts, notably from its Digital Forensics division and the integration of CDFS.

Group 6 Metals Limited reveals a challenging quarter marked by safety incidents and production setbacks at its Dolphin Tungsten Mine, while initiating a major recapitalisation plan to stabilise finances and leadership.

Chimeric Therapeutics has dosed the first three patients in its Phase 1/2 CHM CDH17 CAR-T trial targeting gastrointestinal cancers, alongside advancing its AML and NK cell therapy programs. The company also secured $5 million in funding and appointed Dr Rebecca McQualter as CEO.

Vectus Biosystems reports completion of Phase Ib trials for its lead drug VB0004 and a robust cash position bolstered by a significant R&D tax refund, setting the stage for licensing discussions.

Dotz Nano Limited has landed its first commercial order for DotzShield in the U.S. and made significant strides in carbon capture technology development, including a new sorbent for Direct Air Capture and a strategic collaboration with Bar-Ilan University.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

Structural Monitoring Systems plc has raised $8.7 million and implemented a major cost restructuring, positioning itself for profitable growth with strong sales momentum in its avionics and sensor technology segments.

Marquee Resources delivers a robust December quarter update, spotlighting strong drilling results at Redlings Rare Earth Project and a maiden Inferred Mineral Resource Estimate, while advancing exploration across multiple strategic projects.

Globe Metals & Mining has reached a pivotal funding milestone with a US$10 million convertible loan agreement, propelling the Kanyika Niobium Project closer to development. The updated feasibility study remains on track for completion by March/April 2025, underpinning the project's execution phase.

Andromeda Metals has made significant strides in advancing its Great White Project, progressing funding efforts for Stage 1A+ and securing key operational milestones. The company also bolstered its leadership with new board appointments and received a substantial tax refund, positioning it for a critical investment decision.

Lincoln Minerals reports compelling Pre-Feasibility Study results for its Kookaburra Graphite Project, alongside strategic cost reductions and exploration progress in uranium and base metals on South Australia's Eyre Peninsula.

Peninsula Energy Limited reported a substantial cash outflow in the December 2024 quarter, driven by significant investing activity related to its Lance Projects. The company is actively pursuing additional funding to support upcoming production scale-up.

Peninsula Energy has resumed uranium production at its flagship Lance Projects in Wyoming after a five-year pause, marking a pivotal step towards becoming a fully independent uranium producer. The company also announced key executive appointments and progress on plant construction despite some cost overruns and operational challenges.

Australian Pacific Coal has marked a significant milestone with the first commercial coal shipment from its Dartbrook mine, backed by a substantial financing boost and ongoing infrastructure upgrades.

Accelerate Resources has successfully raised $1.35 million to accelerate exploration at its newly acquired Kanowna East Gold Project, marking a strategic push into the prolific Kalgoorlie gold region.

Emperor Energy has secured $3 million through a share placement to fund the Judith-2 Well development, appointing a suite of technical consultants to accelerate progress in the Gippsland Basin. The company’s strategic moves position it to unlock significant gas resources critical for South-Eastern Australia’s energy supply.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Norfolk Metals reports progress in its Orroroo Uranium and Roger River projects, unveiling new exploration targets and maintaining a solid financial footing with $2.66 million in cash.

Western Yilgarn NL reports encouraging exploration results at its Ida Holmes Project, alongside a successful capital raising and strategic board changes, setting the stage for accelerated development in 2025.

Superior Resources Limited reports significant progress in its Steam Engine Gold Project and Bottletree Cu-Au-Mo Porphyry Prospect, while addressing assay errors that have delayed some results.